Preview

Moscow Surgical Journal

Advanced search

COMPARATIVE ANALYSIS OF PERCUTANEUS UNI- AND BILOBAR STENTING IN NON-RESECTABLE MALIGNANT HILAR OBSTRUCTION

https://doi.org/10.17238/issn2072-3180.2020.4.16-20

Abstract

Objective. To conduct a comparative analysis of uni- and bilobar stenting in unresectable malignant biliary hilar obstruction.
Material and methods. In the Botkin hospital (Moscow) from 2015 to 2019 antegrade self-expanding stenting was performed in 61 patients with unresectable malignant hilar obstruction. The patients were divided into 2 groups: group 1 — 27 had unilobar stenting and group 2 — 34 bilobar stenting. Patient characteristics: average age group 1 — 67.4±4.8, group 2 — 71.2±5.2; gender (m/f) group 1 — 12/15, group 2 — 19/15; bismuth type (II / IIIa / IIIb) group 1 — 6/11/10, group 2 — 4/18/12; ECOG group 1 — 2.4 ± 0.5, group 2 — 2.6 ± 0.4 (homogeneous groups).
Results. Technical success: group 1 — 93.1%, group 2 — 82.9% (p = 0.293); clinical success: group 1 — 77.8%, group 2 — 88.2% (p = 0.147). The complication rate was slightly lower in the first group, 4 out of 27 (14.8%) versus 7 out of 34 in the second (20.6%) (p = 0.293). The frequency of stent dysfunctions in the first 3 months was 10 (35.7%) in group 1 and 7 (41.2%) in group 2 (p = 0.238). The stent functioning time was 241 days in group 1 and 319 days in group 2 (p = 0.325). Subgroup analysis revealed a significant difference (p = 0.019) in a more rapid decrease in bilirubin in the group of patients without cholangitis. The median survival was not statistically significant.
Conclusion. As a result of the study, it can be concluded that the results of uni- and bilibar stenting do not significantly differ in the dynamics of laboratory parameters, the number of complications, and the duration of stent functioning.

About the Authors

A. V. Shabunin
Department of Surgery, Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation; Botkin Hospital
Russian Federation

Alexey Shabunin — Corresponding Member RAS, Professor, Doctor of Medical Sciences, Head of the Department of Surgery of the FSBEI DPO RMANPO of the Ministry of Health of the Russian Federation, Chief Physician of the Botkin Hospital, Moscow Department of Health

125284, st. 2nd Botkinsky proezd, 5, Moscow



S. S. Lebedev
Department of Surgery, Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation; Botkin Hospital
Russian Federation

Sergey Lebedev — PhD in Medicine, Associate Professor of the Department of Surgery of the Federal State Budgetary Educational Institution of Higher Professional Education RMANPO of the Ministry of Health of the Russian Federation, surgeon of Botkin Hospital

125284, st. 2nd Botkinsky proezd, 5, Moscow



M. M. Tavobilov
Department of Surgery, Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation; Botkin Hospital
Russian Federation

Mikhail Tavobilov — Doctor of Medical Sciences, Associate Professor of the Department of Surgery of the FSBEI DPO RMANPO of the Ministry of Health of the Russian Federation, Head of the Department of Botkin Hospital

125284, st. 2nd Botkinsky proezd, 5, Moscow



G. M. Chechenin
Department of Surgery, Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation; Botkin Hospital
Russian Federation

Grigory Chechenin — PhD in Medicine, Associate Professor of the Department of Surgery of the FSBEI DPO RMANPO of the Ministry of Health of the Russian Federation, surgeon of Botkin Hospital, Moscow Department of Health

125284, st. 2nd Botkinsky proezd, 5



A. A. Karpov
Botkin Hospital
Russian Federation

Alexey Karpov — surgeon

125284, st. 2nd Botkinsky proezd, 5



P. A. Drozdov
Botkin Hospital
Russian Federation

Pavel Drozdov — head of the department

125284, st. 2nd Botkinsky proezd, 5, Moscow



A. A. Ismati
Russian Medical Academy of Continuing Professional Education, Ministry of Health of the Russian Federation
Russian Federation

Amir Ismati — resident of the Department of Surgery

125284, st. 2nd Botkinsky proezd, 5



References

1. Chang G., Xia F.F., Li H.F., Niu S., Xu Y.S. Unilateral versus bilateral stent insertion for malignant hilar biliary obstruction. Abdom. Radiol. (NY), 2017, No. 42, рр. 2745–2751.

2. Li M., Bai M., Qi X. et al. Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: Results and predictive factors for efficacy in 159 patients from a single center. Cardiovasc. Intervent. Radiol., 2015, No. 38, рр. 709–721.

3. Fu Y.F., Zhou W.J., Shi Y.B., Cao W., Cao C. Percutaneous stenting for malignant hilar biliary obstruction: A randomized controlled trial of unilateral versus bilateral stenting. Abdom. Radiol. (NY), 2019, No. 44, рр. 2900–2908.

4. Lee T.H., Kim T.H., Moon J.H. et al. Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: A multicenter, prospective, randomized study (with video). Gastrointest. Endosc., 2017, No. 86, рр. 817–827.

5. Hann L.E., Getrajdman G.I., Brown K.T. et al. Hepatic lobar atrophy: association with ipsilateral portal vein obstruction. AJR, 1996, No. 167, рр. 1017–1021.


Review

For citations:


Shabunin A.V., Lebedev S.S., Tavobilov M.M., Chechenin G.M., Karpov A.A., Drozdov P.A., Ismati A.A. COMPARATIVE ANALYSIS OF PERCUTANEUS UNI- AND BILOBAR STENTING IN NON-RESECTABLE MALIGNANT HILAR OBSTRUCTION. Moscow Surgical Journal. 2020;(4):16-20. (In Russ.) https://doi.org/10.17238/issn2072-3180.2020.4.16-20

Views: 546


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-3180 (Print)